Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
NAIROBI/DAKAR, Oct 6 (Reuters) - The World Health Organization (WHO) said on Wednesday the only approved vaccine against malaria should be widely used on African children, potentially a major advance against a disease that kills hundreds of thous...
Read more* Could offer an alternative advance protection for COVID-19* Addressing people with weakened immune system* Part of monoclonal antibody drug class (Writes through)By Ludwig Burger and Sachin RavikumarOct 5 (Reuters) - AstraZeneca has requested eme...
Read more(Adds details on treatment, background on vaccine)By Ludwig Burger and Sachin RavikumarOct 5 (Reuters) - AstraZeneca has requested emergency use authorisation from U.S. regulators for its new treatment to prevent COVID-19 for people who respond po...
Read more
GSK's ViiV eyes another US green light for child HIV treatment
Read moreFRANKFURT, Sept 30 (Reuters) - Germany's Merck KGaA and Britain's GlaxoSmithKline on Thursday ended their collaboration on cancer treatment bintrafusp alfa, once seen as one of Merck's most promising experimental drugs.Merck said the move was a mu...
Read moreTOP NEWS: GSK's ViiV posts positive three-year switch data for dovato
Read moreGlaxoSmithKline's ViiV gets FDA priority review for HIV drug
Read more* To focus on more conventional COVID-19 vaccine with GSK* To pursue mRNA technology in influenza, other vaccines* Started testing mRNA flu shot in humans in June (Adds quotes from Sanofi)PARIS, Sept 28 (Reuters) - Sanofi is dropping plans for its ...
Read more(Adds market reaction, background on next-gen flu shots)PARIS, Sept 28 (Reuters) - Sanofi is dropping plans for its own mRNA-based COVID-19 vaccine because of the dominant role of the BioNTech-Pfizer alliance as well as Moderna in the fight agains...
Read more* To focus on more conventional COVID-19 vaccine with GSK* To pursue mRNA technology in influenza, other vaccines* Started testing mRNA flu shot in humans in June (Adds exec quote on prospect of annual shots)By Sarah White and Ludwig BurgerPARIS, Se...
Read more(Adds details, background)PARIS, Sept 28 (Reuters) - French healthcare company Sanofi announced on Tuesday positive Phase I/II study interim results for its first mRNA-based COVID-19 vaccine candidate.Sanofi said initial data from these results s...
Read more(Adds background, orders of protein-based shots)PARIS, Sept 28 (Reuters) - Sanofi is dropping plans for its own mRNA-based COVID-19 vaccine because of the dominant role of the BioNTech-Pfizer alliance as well as Moderna in the fight against the pa...
Read more(Recasts, adds details)PARIS, Sept 28 (Reuters) - Sanofi is dropping plans for its own mRNA-based COVID-19 vaccine because of the dominant role of the BioNTech-Pfizer alliance as well as Moderna in the fight against the pandemic, the company said...
Read more(Adds details throughout)PARIS, Sept 28 (Reuters) - Sanofi on Tuesday announced positive interim results from its early-stage study for the mRNA-based COVID-19 vaccine candidate it is developing with Translate Bio, a boost for the French drug comp...
Read more
Last checked at